The tigecycline resistance mechanisms in Gram-negative bacilli

Tigecycline, hailed as a pivotal agent in combating multidrug-resistant bacterial infections, confronts obstacles posed by the emergence of resistance mechanisms in Gram-negative bacilli. This study explores the complex mechanisms of tigecycline resistance in Gram-negative bacilli, with a particular focus on the role of efflux pumps and drug modification in resistance. By summarizing these mechanisms, our objective is to provide a comprehensive understanding of tigecycline resistance in Gram-negative bacilli, thereby illuminating the evolving landscape of antimicrobial resistance. This review contributes to the elucidation of current existing tigecycline resistance mechanisms and provides insights into the development of effective strategies to manage the control of antimicrobial resistance in the clinical setting, as well as potential new targets for the treatment of tigecycline-resistant bacterial infections.

1 Introduction

Antimicrobial resistance is one of the most significant public health problems of our time. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have classified antibiotic-resistant pathogens as an imminent threat to human health (De Oliveira et al., 2020). The increased use of antimicrobial agents has led to an increase in the incidence of multidrug-resistant (MDR) or extensively drug-resistant (XDR) bacterial pathogens, which in turn has resulted in a rise in the number of prolonged hospitalizations, morbidity, and mortality cases. This has placed a significant economic burden on the healthcare system (Yaghoubi et al., 2022). Tigecycline, a tetracycline derivative, and colistin, a polymyxin, have been regarded as the “last line” of treatment for infections caused by MDR Gram-negative bacteria. However, the emergence of resistance has aroused widespread concern in recent years (Peng et al., 2022a).

Tetracyclines represent a class of compounds with a broad spectrum of antimicrobial activity, including Gram-positive and negative bacteria, spirochetes, intracellular bacteria, and parasites (Grossman, 2016). Tetracyclines encompass a diverse range of agents, from the naturally synthesized tetracyclines and chlortetracycline, which were introduced for medical use in the 1940s, to the second-generation semisynthetic derivatives doxycycline and minocycline, and the novel third-generation semisynthetic derivative tigecycline (Nguyen et al., 2014). In addition to the previously mentioned tetracyclines, new semisynthetic derivative omadacycline, and fully synthesized derivative eravacycline have been developed recently (Deolankar et al., 2022). These novel derivatives offer enhanced efficacy over first- and second-generation tetracyclines against challenging MDR Gram-negative and positive pathogens, including bacteria with tetracycline-specific resistance mechanisms (Grossman, 2016).

Tigecycline represents a novel semi-synthetic glycylcycline, a 9-t-butylglycinamido derivative of minocycline (Petersen et al., 1999). It can reversibly bind to 16S rRNA in the 30S subunit of the ribosome upon entry into the bacterial, thereby blocking tRNA access to the A-site and inhibiting the protein transcription-translation process. It was first introduced into clinical use in the United States in 2005 and subsequently entered the clinical setting in China in 2011. Due to the presence of a large substituent at position 9, it forms a large steric hindrance that can overcome the two major determinants of tetracycline resistance caused by ribosomal protection proteins Tet(M) and Tet(O) as well as the active efflux pumps Tet(A) and Tet(K) (Pankey, 2005; Pournaras et al., 2016). Tigecycline exhibits high in vitro activity against a wide range of Gram-positive and negative aerobic and anaerobic bacteria, including Staphylococcus aureus, Haemophilus influenzae, Neisseria gonorrhoeae, Enterococci, Clostridium spp., Enterobacteriaceae, Bacillus spp., and others, except Pseudomonas aeruginosa, Proteus spp., and Morganella spp. (Pankey, 2005). In addition to its approved use for complicated skin and skin structure infections, complicated abdominal infections, and community-acquired bacterial pneumonia in adults, recent reports have demonstrated the efficacy of tigecycline in the treatment of severe Clostridium. difficile infections (Kechagias et al., 2020). Due to its superior ability to inhibit the methicillin-resistant S.aureus, vancomycin-resistant Enterococci, and carbapenem-resistant Enterobacteriaceae, tigecycline remains a valuable therapeutic option for the treatment of severe infections caused by MDR pathogens. The tigecycline resistance mechanisms in Gram-negative bacilli have been extensively studied, revealing a wide distribution of resistance mechanisms across various species, along with some mechanisms that are specific to particular species.

2 Resistance mechanisms associated with efflux pumps and regulatory genes

Among the mechanisms of tigecycline resistance, the efflux pump, particularly the resistance-nodulation-cell division (RND) type efflux pumps, is essential. Inherent resistance in P. aeruginosa, Proteus mirabilis, and Morganella morganii has been reported to be mediated by two RND efflux pumps, MexXY-OprD and AcrAB (Pournaras et al., 2016). The tigecycline resistance-related efflux pumps and the regulatory genes have been documented in Table 1.

Table 1

Table 1. Specific information on efflux pumps and its regulatory genes.

2.1 RND efflux pump AcrAB/EF

The RND efflux pump AcrAB has been documented to be associated with tigecycline resistance in different strains. One study conducted transposon-mutagenesis of tigecycline resistant clinical Enterobacter cloacae isolates to obtain susceptible mutants (Keeney et al., 2007). The results indicated that mutants had transposon insertions in the acrA or acrB genes, whereas the complementation of the acrAB cloning plasmid restored their resistance phenotypes. Further RNA blotting demonstrated that the acrAB transcription was elevated in all strains exhibiting reduced tigecycline susceptibility. The overexpression of acrAB was observed to be associated with an increase in the expression of the transcriptional regulatory gene ramA, suggesting that tigecycline resistance in E. cloacae is a consequence of RamA-mediated overexpression of the AcrAB efflux pump. Liu et al. also demonstrated that the overexpression of regulatory genes ramA and soxS was associated with heterogeneous resistance to tigecycline (Liu et al., 2019). It was observed that the AcrAB and OqxAB efflux pumps were notably overexpressed in carbapenem-resistant tigecycline heterogeneous resistant E. cloacae, in which the increased expression of their regulatory genes ramA and/or soxS was presumed to be a key factor in the heterogeneous resistance of tigecycline.

In Escherichia coli, it has been reported that the transcriptional activator MarA is associated with the overexpression of the AcrAB efflux pump (Keeney et al., 2008). The transcriptional analysis of homozygous clinical isolates isolated from the same patient revealed that the expressions of marA, acrA, acrB, and tolC were significantly increased in strains with higher tigecycline minimum inhibitory concentrations (MICs). Transposon mutagenesis was also employed to generate tigecycline susceptible mutants, with the analysis revealing that the majority of which were marA or AcrB inactivated. Further sequence analysis showed a single nucleotide insertion (354_355insC) in the open reading frame of the marR gene in E. coli with higher tigecycline MICs, suggesting that the overexpression of MarA and AcrAB caused by the loss of MarR function due to the frame-shift mutation might, in turn, reduce the susceptibility to tigecycline. Furthermore, the AcrEF efflux pump in E. coli has been documented to be associated with decreased tigecycline sensitivity (Hirata et al., 2004). A series of research has identified that the loss-of-function mutation in the protease Lon in Klebsiella pneumoniae, E. coli, and Salmonella typhimurium can also cause tigecycline resistance (Nicoloff and Andersson, 2013; Fang et al., 2016; Linkevicius et al., 2016). Lon is involved in the degradation of MarA, and its inactivation leads to the overexpression of MarA and increases the expression of the AcrAB efflux pump, which in turn may result in resistance.

The overexpression of AcrAB and AcrEF in Salmonella enterica also results in tigecycline resistance (Horiyama et al., 2011). Horiyama et al. investigated the tigecycline MICs of S. enterica strains that overexpress or delete efflux pump and regulatory genes. The deletion of acrAB was found to increase the susceptibility to tigecycline, while the complementation of both acrAB and acrEF would restore the MIC in the deletion strains. Both the overexpression of ramA and the deletion of the negative regulatory gene ramR decreased the susceptibility but remained unchanged in the acrAB-deletion strains, suggesting that AcrAB and AcrEF confer resistance to tigecycline in S. enterica with the regulation of RamA and RamR. Moreover, the overexpression of the AcrAB efflux pump, which is the result of frame-shift and deletion mutations in ramR and amino acid substitution mutations in ramA, is the primary cause of tigecycline resistance in E. aerogenes (Veleba et al., 2013). Decreased tigecycline susceptibility caused by ramR mutations has also been observed in E. hormaechei (Gravey et al., 2020). Gravey et al. found an E. hormaechei isolate developed tigecycline resistance in a hospitalized patient after treatment without any relevant resistance genes acquisition except for a 16 bp deletion in ramR, which resulted in the overexpression of RamA, AcrAB, and TolC, as well as the downregulated expression of pore protein OmpF. This indicated that partial deletion of the ramR can lead to the overexpression of RamA, which in turn causes the increased efflux of AcrAB-TolC and decreased antibiotic permeability through OmpF, collectively contributing to tigecycline resistance.

AcrAB overexpression associated with tigecycline resistance in K. pneumoniae is frequently accompanied by the increased transcription of ramA and the inactivation mutations of ramR, and overexpression of the global regulators rarA and marA (Bratu et al., 2009; Hentschke et al., 2010b; Veleba et al., 2012a; Roy et al., 2013; Sheng et al., 2014; Villa et al., 2014; Zhong et al., 2014; Wang et al., 2015; Fang et al., 2016). Sequence analysis revealed that approximately 83% of tigecycline non-susceptible K. pneumoniae carried mutations in ramR and/or local repressor acrR, including missense or nonsense mutations, insertions, and deletions in ramR, as well as amino acid substitutions and frame-shift mutations in acrR. The results of real-time quantitative PCR (RT-qPCR) demonstrated increased expression of the acrB in all resistant strains, indicating that the combination of RamR and AcrR mutations might be involved in the reduced susceptibility to tigecycline (Moghimi et al., 2021). Mutations in the acrR gene may also be related to tigecycline non-susceptibility. Through the antimicrobial susceptibility tests in the presence of the efflux pump inhibitor, Zhang et al. isolated an efflux pump-related tigecycline non-susceptible K. pneumoniae strain only with a frame-shift mutation in acrR caused by a 2 bp deletion, suggesting that the acrR gene mutation might be associated with reduced tigecycline susceptibility (Zhang et al., 2021c). Furthermore, mutations in the negative regulatory genes ramR and soxR were also found to be relevant with tigecycline heterogeneous resistance in K. pneumoniae (Zhang et al., 2021a). A heterogeneous resistance subpopulation was identified in tigecycline-sensitive K. pneumoniae by the disk diffusion method, in which mutations in ramR and soxR were found. The mutations would induce the expression of ramA and soxS, which in turn would cause the overexpression of AcrAB-TolC, thereby resulting in tigecycline heterogeneous resistance and resistance.

2.2 RND efflux pump OqxAB

OqxAB is also a class of RND efflux pumps that have been involved with tigecycline resistance. Previous study has investigated the expression of efflux pumps and regulatory genes in tigecycline-resistant K. pneumoniae by RT-qPCR (Zhong et al., 2014). The results presented that the susceptible strains exhibited higher expression levels for both oqxB and the regulatory gene rarA in OqxAB. For isolates with MICs up to 8 mg/L, the AcrAB-TolC efflux pump plays the most important role in tigecycline resistance, in contrast, both the AcrAB-TolC and OqxAB efflux pumps are required for isolates with MICs ≥ 16 mg/L. The overexpression of rarA in K. pneumoniae has been reported to upregulate the neighboring OqxAB efflux pump, resulting in tigecycline resistance (Veleba and Schneiders, 2012b). The knockout of another regulator ramA showed a slight increase in tigecycline susceptibility, further resistance screening revealed that the transcription of oqxAB, acrAB, rarA, and marA were significantly elevated in the resistant strains (Veleba and Schneiders, 2012b). This indicated that regulators RarA and MarA provide an alternative pathway for tigecycline resistance in K. pneumoniae. Chen et al. also found OqxAB efflux pump was associated with tigecycline heterogeneous resistance in S. enterica (Chen et al., 2017). The addition of the efflux pump inhibitor restored the susceptibility of tigecycline and reduced its accumulation in the cells, suggesting that the heterogeneous resistance was due to the overexpression of the AcrAB-TolC and OqxAB efflux pumps (Chen et al., 2017).

2.3 RND efflux pump Ade family

It has been reported that the overexpression of three RND efflux pumps, AdeABC, AdeFGH, and AdeIJK, is associated with tigecycline resistance in Acinetobacter baumannii (Coyne et al., 2011). AdeABC plays a significant role in the efflux of tigecycline, while the two-component system AdeSR, which contains a sensor kinase protein AdeS and a regulatory protein AdeR, regulates the transcription of the efflux pump. In contrast, AdeFGH is regulated by the LysR-type transcriptional regulator AdeL, and AdeIJK is regulated by the TetR transcriptional regulator AdeN. Many previous studies have found that the tigecycline resistance caused by elevated levels of efflux pump transcription may be related to amino acid substitutions or insertions of insertion sequences (ISs) in regulatory genes (mutation sites are shown in Table 2) (Coyne et al., 2010; Rumbo et al., 2013; Yoon et al., 2013; Yoon et al., 2015; Sun et al., 2016; Hua et al., 2021; Lucaßen et al., 2021a; Lucaßen et al., 2021b; Salehi et al., 2021). The most common insertion sites for ISAba1 are positions 371, 379, 422, and 430 of adeS and positions 52, 200, and 402 of adeR. Nevertheless, the tigecycline resistance resulting from the ISAba1 insertion at adeS is prone to instability during successive passages in the absence of tigecycline, which belongs to heterogeneous resistance, and can be reversed to a susceptible strain by additional insertion of ISAba1 into adeR (Jo and Ko, 2021).

Table 2

Table 2. Common amino acid mutation sites in Ade efflux pumps and regulatory genes.

The most prevalent and widely distributed mechanism identified is the inactivation of the AdeIJK repressor gene adeN, which may have been caused by premature stop codon resulting from ISs insertion or nucleotide deletion. In contrast, mutation or inactivation of the AdeABC regulatory system adeRS occurs less frequently but is often associated with higher tigecycline MICs (Lucaßen et al., 2021a). Lucaßen et al. have evaluated the effect of frequently reported amino acid substitutions on adeB expression, efflux activity, and tigecycline susceptibility through the construction of related knockout and complementary strains (Lucaßen et al., 2021b). The complementation of D26N mutant AdeR and T156M mutant AdeS into the adeRS knockout strain led to higher tigecycline MICs as well as a significant increase in adeB expression and antibiotic efflux. Conversely, the complementation with D21V mutant AdeR did not affect the susceptibility or efflux pump expression, indicating that amino acid substitutions D26N (AdeR) and T156M (AdeS) disrupted their regulatory functions and impacted the efflux. Another two-component regulatory system baeRS has also been shown to affect the tigecycline susceptibility in A. baumannii through the upregulation of adeAB (Lin et al., 2014). In addition to the aforementioned transcriptional regulators, the expression of adeABC can be overexpressed under low iron environments, indicating the potential for additional regulation of the efflux pump by iron (Modarresi et al., 2015).

The global regulator SoxR has been reported to increase tigecycline susceptibility by affecting the expression of efflux pumps (Li et al., 2017). Li et al. compared the molecular characterization between MDR and tigecycline susceptible A. baumannii strains and found that the frequency of the G39S mutation in SoxR was higher in MDR strains. Further overexpression of soxR revealed a minor decrease in tigecycline MIC and a reduction in the expression of the efflux pump genes adeJ and adeG, the small multidrug resistance family gene abeS, and the multidrug and toxic compound extrusion gene abeM, suggesting that SoxR might act as a negative regulator of efflux pump and contribute to tigecycline resistance in A. baumannii.

Moreover, the overexpression of the Ade efflux pump has been documented in A. nosocomialis and A. pittii. One study investigated the contribution of the RND efflux pump to tigecycline resistance in A. nosocomialis, focusing on the expression of the RND efflux pump and the adeR mutation (Yang et al., 2019). The RT-qPCR results revealed that tigecycline non-susceptible isolates exhibited a significantly increase transcription of adeB compared to susceptible ones, indicating that AdeABC was the major efflux pump related with tigecycline non-susceptible in A. nosocomialis. Further comparative sequence analysis identified five amino acid substitutions in AdeR and AdeS, including S16N and H56L in AdeS, D299N, T137N, and A220E in AdeR. The significant increases in the transcription of adeB and adeJ correlated with tigecycline resistance were also observed in tigecycline resistant A. pittii (Ding et al., 2022).

2.4 Other chromosome-localized RND efflux pumps

There are three intrinsic RND efflux pumps, namely SdeAB, SdeCDE, and SdeXY, in Serratia marcescens, whose efflux has been confirmed to be an important mechanism for tigecycline resistance (Hornsey et al., 2010). Hornsey et al. conducted the mutation screening by successive passaging under tigecycline pressure, resulting in the isolation of a mutant with a 256-fold increase in tigecycline MIC. The RT-qPCR analysis revealed that all three RND efflux pumps were overexpressed in the mutant, while the transcription of sdeXY was significantly higher than others. Further investigation of the constructed mutant indicated that the tigecycline MIC was significantly decreased when sdeY and the putative outer membrane component gene hasF were inactivated, suggesting that the overexpressed SdeXY-HasF pump was the possible reason for the tigecycline resistance in S. marcescens.

The overexpression of RND efflux pump SmeDEF is a predominant contributing factor for tigecycline resistance in Stenotrophomonas maltophilia (Blanco et al., 2019). During the experimental evolution, the tigecycline-evolved populations attained resistance through different mutational trajectories, with all initial mutations occurring in the SmeDEF repressor smeT, which might result in the overexpression of the efflux pump. An RND efflux pump, AxyEF-OprN, which mediates tigecycline efflux has also been identified in Achromobacter xylosoxidans (Nielsen et al., 2019). Following targeted AxyEF by transcriptome analysis, the study knocked down axyE and found a decrease in tigecycline MIC, demonstrating that AxyEF-OprN might efflux tigecycline and interfere with tigecycline resistance.

2.5 Plasmid-mediated RND efflux pumps

Previous studies have indicated that RND efflux pump gene clusters on plasmids may contribute to tigecycline resistance. Lv et al. identified a novel RND efflux pump gene cluster, tnfxB1-tMexCD1-toprJ1, on plasmids from pan-resistant K. pneumoniae (Lv et al., 2020b). The overexpression of the cluster resulted in the elimination of the in vitro and in vivo accumulation of tigecycline in bacteria, suggesting that TMexCD1-TOprJ1 could mediate tigecycline efflux and generate resistance that might lead to tigecycline treatment failure. Plasmids with TMexCD1-TOprJ1 have been discovered in Asia, Europe, and North America, indicating a risk of global spread of tigecycline resistance. Furthermore, a plasmid co-localizing tmexCD1-toprJ1 and the colistin resistance gene mcr has been reported in K. pneumoniae, which also carried an IncX3 plasmid with bla_NDM (Sun et al., 2020). The emergence of the mobile tigecycline and colistin resistance poses a substantial threat to public health, underscoring the urgent need for further global surveillance.

A novel plasmid-mediated RND efflux pump gene cluster, tnfxB2-tmexCD2-toprJ2, which exhibits high similarity to tnfxB1-tMexCD1-toprJ1, has been identified on the chromosome and plasmid of Raoultella ornithinolytica (Wang et al., 2021b). The overexpression of tmexCD2-toprJ2 demonstrated an 8-fold increase in tigecycline MIC, while the genetic environment analysis revealed its translocated potential between the plasmids and chromosomes. This cluster has been reported in various Klebsiella spp., and novel related isoforms tmexC1D1.2-toprJ1 and tmexC2D2.2-toprJ2 have also been identified in P. aeruginosa and Klebsiella spp, indicating that this plasmid-mediated tigecycline resistance mechanism has already spread among isolates and improved detection is necessary to prevent the resistance crisis (Wang et al., 2021d; Sun et al., 2022).

In addition to tmexCD1/2-toprJ1/2 and tmexCD3-toprJ3, which has been found in Proteus spp. and P. aeruginosa (Wang et al., 2021a), a fourth tmexCD-toprJ-like gene cluster, tmexCD4-toprJ4, has been identified in plasmids from K. quasipneumoniae and Enterobacter roggenkampii that mediates tigecycline resistance (Gao et al., 2022). The overexpression of tmexCD4-toprJ4 resulted in increased tigecycline efflux and MICs. Gao et al. further found that tmexCD4-toprJ4 could act synergistically with its upstream tet(A) to reduce the susceptibility. A recent epidemiological study of the clinical prevalence, genomic, and phenotypic characterization of tmexCD-toprJ has shown that among 7,517 clinical isolates collected in China, 48 isolates carried tmexCD-toprJ (0.64%), all of which were MDR and possessed other resistance genes simultaneously (Dong et al., 2022b). The presence of mobile elements in the genetic environment suggests that it may be capable of propagating among different species, prompting the necessity for monitoring and control of the further spread.

2.6 MFS efflux pumps

The major facilitator superfamily (MFS) efflux pumps represent another class of efflux pumps involved in tigecycline resistance. It has been demonstrated that the RND-type efflux pumps AdeABC and AdeIJK can synergize with the MFS efflux pump TetA to induce tigecycline resistance in A. baumannii (Foong et al., 2020). Foong et al. overexpressed tet(A) in the RND efflux pump knockout strains and detected decreased tigecycline MICs in tigecycline susceptible adeAB and adeIJ knockout strains, suggesting that the TetA pump played an important role in tigecycline efflux with AdeABC and AdeIJK acting in a synergistic and/or additive manner.

Mutations in the tet(A) gene have been associated with reduced tigecycline susceptibility in carbapenem-resistant K. pneumoniae (CRKP) (Chiu et al., 2017; Xu et al., 2021b; Peng et al., 2022b). Sixteen CRKP strains were found to have individual (81%) or combination (63%) mutations in ramR and tet(A) (Chiu et al., 2017). Through the complementation into the tet(A)/ramR-deficient strains, they discovered a notable elevation in tigecycline MICs in tet(A) frame-shift mutants complementary strains, meanwhile, a synergistic effect of resistance was observed in strain without ramR but a mutated tet(A) compared to the wild-type strain overexpressing the mutated tet(A). This implied that mutations in ramR and tet(A) might be the primary mechanism of tigecycline resistance and act synergistically. Another study performed whole genome sequencing of 63 CRKP isolates and chose isolates with tet(A) to conduct tigecycline resistance screening under selective pressure (Xu et al., 2021b). They identified that 71.4% of the tigecycline non-susceptible strains were found to have tet(A) mutations and exhibit high-level tigecycline resistance. These amino acid substitutions were confirmed in E. coli as the overexpression strains showed a 2-8-folds increase in tigecycline MICs.

The tigecycline resistance caused by tet(A) and ramR mutations is also present in S. enterica. Hentschke et al. discovered a tet(A) mutant that was located on a plasmid with Tn1721 in tigecycline resistance S. enterica and increased tigecycline MIC when transferred to E. coli (Hentschke et al., 2010a). The isolate also possessed a frame-shift mutation in ramR and the overexpression of the mutants did not affect tigecycline susceptibility compared to the increase when overexpressed wild-type ramR. It indicated that the resistance might related to the enhanced efflux of AcrAB through the up-regulation of RamA resulting from ramR mutation. Together with tet(A) mutation, these two mechanisms mediating low-level resistance may act synergistically, leading to high-level tigecycline resistance. The same synergetic effect has been identified in tigecycline non-susceptible S. enterica with tet(A) frame-shift mutation (Akiyama et al., 2013). This confirmed that tet(A) could decrease sensitivity to tigecycline at a low level, with ramR inactivation acting as an additional resistance mechanism that might confer high-level resistance.

Another MFS efflux pump, Tet(Y), has also been reported to be associated with tigecycline resistance in A. baumannii (Wang et al., 2021c). Whole-genome sequencing identified an isolate without any known tigecycline resistance genes and mutations but carried a novel MFS efflux pump-encoding gene, tet(Y) on its plasmid. The overexpression of tet(Y) and tet(Y) plasmid could increase the tigecycline MICs, indicating that tet(Y) is related to tigecycline susceptibility reduction. The adjacent Tn5393 in its genetic background suggested that resistance caused by the novel plasmid carrying tet(Y) might be transmitted between isolates.

Tet(L), an MFS efflux pump often reported in Gram-positive bacteria, has been discovered in Gram-negative bacteria recently. Sun et al. identified tet(L) in tigecycline-susceptible Moraxella catarrhalis, implying that it does not affect tigecycline resistance in M. catarrhalis (Sun et al., 2021). A variant of tet(L) was identified in the chromosomes of Campylobacter spp. with a prevalence rate of approximately 17%, of which the overexpression revealed a 4-fold increase in MIC (Yao et al., 2020). Genetic environment analysis revealed that the tet(L) variant was located in a genomic island with IS1216E and other resistance genes inserted into the conserved gene potB, suggesting that the variant might not only mediate resistance but also spread through horizontal gene transfer.

2.7 Other efflux pump

Except for the aforementioned common efflux pump families, novel efflux pumps associated with tigecycline resistance continue to be identified. An efflux pump, KpgABC, was identified in K. pneumoniae, which was associated with tigecycline nonsusceptibility (Nielsen et al., 2014). Following an increase in tigecycline MIC from 1 mg/L to 4 mg/L in clinical strains collected before and during patient tigecycline treatment, and no increase in the expression of known efflux pump-associated genes as revealed by RT-qPCR studies, whole-genome sequencing was performed to identify putative novel resistance genes. An IS5 insertion in the upstream of a putative efflux pump, which was named KpgABC, was identified. A 4-fold increase in MIC after overexpression of kpgABC verified its role in the reduction of tigecycline sensitivity.

3 Resistance mechanisms associated with antibiotic modification

tet(X) genes encode a flavin-dependent monooxygenase that modifies tetracyclines, rendering them inactive. It is capable of inactivating all tetracycline antimicrobial agents, including tigecycline and eravacycline, while mobile genetic elements like transposons often mediate its spread (Anyanwu et al., 2022). The tet(X) genes that have been identified to date include tet(X), tet(X1-X15), and tet(X18-X47), with the distribution illustrated in Table 3. tet(X), tet(X1) and tet(X2) are only vertically transmitted in the environment and microbiota, conferring low levels of resistance to tigecycline, with tet(X1) and tet(X2) shared 66% and 99% identity with tet(X) (Whittle et al., 2001; Yang et al., 2004; Hassan et al., 2018). In recent years, plasmid- or chromosome-localized tet(X3-X6) has been identified as a significant factor contributing to high tigecycline resistance and observed in a diverse range of strains.

Table 3

Table 3. Specific information on tet(X) and its variants.

Plasmid-borne tet(X3) and tet(X4) genes were initially identified in tigecycline-resistant A. baumannii and E. coli from Chinese edible animals and the environment in 2019, exhibiting 85.1% and 94.3% identity to tet(X), respectively (He et al., 2019). The antimicrobial susceptible assay revealed that the overexpression of tet(X3) and tet(X4) in E. coli significantly elevated the tigecycline MICs. Furthermore, the in vivo results demonstrated that tet(X3) and tet(X4) might also affect the tigecycline treatment in the mouse infection model, leading to clinical treatment failure. The genetic background analysis presented that they were both adjacent to the ISVsa3 on their respective plasmids, suggesting the possible transmission between strains. The article also conducted a retrospective analysis and discovered that tet(X3) and tet(X4) are already prevalent in clinical isolates, indicating that the tet(X) variants are emerging as one of the most important tigecycline resistance genes.

tet(X3) and tet(X4) genes were identified in a range of isolates. A screening of tet(X) variants of Acinetobacter species from pig, bird, and human sources in China identified 193 tet(X3)- or tet(X4)-positive Acinetobacter species (5.0%), of which 188 carried tet(X3) and 5 carried tet(X4) (Chen et al., 2020). Seven novel tet(X3) variants were discovered in tigecycline-resistant Acinetobacter species, sharing 15.4%-99.7% amino acid identity with Tet(X3). Only tet(X3.7) and tet(X3.9) could increase the tigecycline MIC and were found to be in proximity to mobile genetic elements and site-specific recombinase xerD (Cheng et al., 2022). tet(X3) identified on Acinetobacter plasmids are often found in proximity to mobile genetic elements, including ISVsa3 (ISCR2), IS4, and IS26, which facilitate its transfer between strains (Zhang et al., 2020; Cheng et al., 2021b; Cheng et al., 2022; Wang et al., 2022b). Other reports have documented that the majority of tet(X4) localized on E. coli plasmids are commonly surrounded by ISVsa3 (ISCR2), while also finding the presence of tet(X4) and mcr-1 co-occurrence plasmid as well as the chromosomally located tet(X4) in E. coli (Chen et al., 2019; Sun et al., 2019; Ding et al., 2020; Li et al., 2020; Lv et al., 2020a; Li et al., 2021b; Mohsin et al., 2021; Chen et al., 2023; Wang et al., 2022a). The identifications of tet(X4) in E. coli, K. pneumoniae, K. quasipneumoniae, Citrobacter braakii, and C. freundii have been reported in the presence of four core genetic backgrounds, all of which are adjacent to ISVsa3 (ISCR2) or IS26 (Li et al., 2021a; Zhai et al., 2022). Dao et al. has discovered tet(X4) in tigecycline- and carbapenem-resistant Shewanella xiamenensis (Dao et al., 2022). It was co-located with bla_OXA-48 on the plasmid and flanked by IS91 family transposase genes, indicating that its acquisition might be mediated by mobile genetic elements. In E. fergusonii, tet(X4) was found in co-occurrence with bla_TEM-1B and floR on a mobile plasmid that was highly homologous to plasmids from E. coli, E. cloacae, and Klebsiella spp. (Guan et al., 2022). Moreover, tet(X4) was identified in an extensively drug-resistant Salmonella enterica (Abd El-Aziz et al., 2021).

A novel plasmid-mediated tet(X) variant, tet(X5), was reported in 2020 in a tigecycline resistant A. baumannii (Wang et al., 2019). Tet(X5) exhibits amino acid identity with Tet(X3) and Tet(X4) at 84.5% and 90.5% with a similar binding site and comparable affinities for tetracyclines, respectively. The overexpression of tet(X5) demonstrated an increase in the MICs of tetracyclines, yet the level of Tet(X5)-mediated tigecycline resistance was slightly lower in comparison to the high-level resistance mediated by Tet(X3/4), as previously reported. A comparable genetic context to that of tet(X3/4) was also identified in tet(X5), suggesting that tet(X) variants might disseminate through ISVsa3. Other reports on tet(X5) in A. baumannii have implied that it is situated within the ISVsa3 (ISCR2)-mediated tet(X) transposon structure, thereby increasing its transmission risk between the environment and the clinic (Chen et al., 2021). tet(X5) has been also identified in other resistant Acinetobacter species (Dong et al., 2022a), Tang has found it co-located with bla_NDM-3 in A. indicus plasmid that mediates tigecycline resistance in the strain (Tang et al., 2021).

tet(X6) was initially identified on the chromosome of Myroides phaeus with the overexpression strains revealing only a 2-4-fold increase in tetracyclines MICs, while its similar adjacency to ISVsa3 might contribute to the transmission (Liu et al., 2020). The reason for its mediation of lower levels of resistance may be attributed to the lower tetracycline-binding capacity of Tet(X6) in comparison to other Tet(X) variants. Further retrospective analysis revealed that tet(X6) was also found in various Proteus spp. and Acinetobacter species. Many reports have identified tet(X6) variants on the chromosome of A. baumannii, Acinetobacter species, Chryseobacterium indologenes, Providencia rettgeri, Ignatzschineria indica, and Oblitimonas alkaliphile (Li et al., 2020; Chen et al., 2021; Hsieh et al., 2021; Li et al., 2021d; Damas et al., 2022; Dong et al., 2022a; Wang et al., 2022b). Additionally, plasmid-localized tet(X6) genes have been detected on tigecycline-susceptible A. towneri plasmid with a genetic background also associated with ISVsa3 (ISCR2) (Cheng et al., 2021a). The detection of tet(X6) in a susceptible plasmid indicates the potential for cryptic spread of this novel plasmid-mediated tigecycline resistance. The majority of reported tet(X6) genes carried by plasmids from Acinetobacter species are located adjacent to ISVsa3 (ISCR2) or ISAba1 and often co-localized with tet(X3), bla_OXA-58 or other resistance genes, with the plasmid conjugates presented increased tigecycline MICs (Zheng et al., 2020; Cheng et al., 2021b; Li et al., 2021d; Chen et al., 2022). Xu and Usui et al. also identified tet(X6) in plasmids from tigecycline-resistant E. coli, which was co-located with mcr-1 in the hotspot of resistance genes, in proximity to a variety of mobile genetic elements such as TnAs1, TnAs3, and ISVsa3 (Usui et al., 2022; Xu et al., 2021a).

In addition to the above tet(X) variants commonly reported about tigecycline resistance, other variants have also been discovered to mediate resistance. A plasmid from a tigecycline-resistant E. coli strain was found to contain tet(X7) with the co-occurrence of mcr-1.1 (Soliman et al., 2021). The tigecycline MIC was significantly elevated after plasmid conjugation, while tet(X7) was adjacent to ISCR3 which might play a role in the transmission of resistance. tet(X14) was identified on tigecycline- and colistin-resistant Empedobacter stercoris, which exhibited 67.14%-96.39% sequence identity with other variants (Cheng et al., 2021a). It was co-localized with tet(X2) on the chromosome and the overexpression of tet(X14) resulted in a significant reduction in the tigecycline susceptibility. With no mobile genetic elements detected in its vicinity, tet(X14) might be a heterologous gene obtained by recombination. Further screening in Genbank revealed that only Riemerella anatipestifer carried tet(X14), leading to the presumption that the Flavobacteriaceae are its reservoir. tet(X15) was discovered on the chromosome of a tigecycline-resistant A. variabilis, with overexpression strains exhibiting elevated tigecycline MICs, suggesting that tet(X15) contributes to reduced tigecycline susceptibility (Li et al., 2021c; Li et al., 2021d). Genetic background analysis indicated that it was located within the ISAba1-binding complex transposon Tn6866 and that ISAba1 might promote the spread of tet(X15).

R. anatipestifer has been reported as a probable source of the tet(X) gene. A tracking screen for tet(X) in public databases revealed that it appeared as early as the 1960s in R. anatipestifer and was the primary tet(X) vector during the initial stages. Comparative genomic analysis indicated that tet(X) variants were likely produced through the dissemination of tet(X) between Flavobacteriaceae and E. coli/Acinetobacter species, with ISCR2 playing a pivotal role, leading to the hypothesis that R. anatipestifer might be a potential natural source of tet(X) (Zhang et al., 2021b). Various tet(X) variants, including tet(X18-X44), were identified on the chromosome and plasmid of R. anatipestifer, and the overexpression strains revealed that most of these variants conferred tigecycline resistance to E. coli, while the less frequently occurring tet(X27/29/30) variants might be recessive or silent (Umar et al., 2021; Zhu et al., 2022). Further analysis implied that these variants were seldom found adjacent to mobile genetic elements, which lent support to the hypothesis that R. anatipestifer is a natural source of tet(X). Zhang et al. have screened the human microbiome samples and identified three novel tet(X) variants, designated tet(X45), tet(X46), and tet(X47), which were found to mediate high levels of tigecycline resistance (Zhang et al., 2021b). The macrogenomic analysis suggested that tet(X) variants were predominantly derived from Bacteroidaceae of the human gut, with ISBf11 and IS4351 being the most likely to mediate the spread. The naming rules for tet(X) variants are somewhat disorganized, and there is a tendency for duplicate nomenclature to occur due to the time at which studies are reported. Consequently, many studies have uniformly referred to newly discovered tet(X) variants as tet(X) variants, rather than numbering them. The above are organized according to the nomenclature that was in use at the time of reporting in the literature. Novel tet(X) variants have been reported on plasmids of K. aerogenes and E. falsenii and both of these variants mediated high-level tigecycline resistance, while the tet(X) variant in K. aerogenes was co-localized with another tigecycline resistance determinant cluster, tmexCD3-toprJ3, on a novel plasmid (Zeng et al., 2020; Hirabayashi et al., 2021).

4 Resistance mechanisms associated with antibiotic binding

4.1 Ribosome-related gene mutations

An amino acid substitution mutation, V57L, in the ribosomal small subunit constitutive protein S10 encoding gene rpsJ has been identified in tigecycline resistant K. pneumoniae, which has been previously reported to relate to tetracycline resistance in Neisseria gonorrhoeae (Villa et al., 2014). This mutation is located at the tip of a conserved flexible loop consisting of amino acids 53-60 in the S10 ribosomal protein and this region is near the tigecycline target site and is associated with the ribosome binding to tigecycline. The article postulated that the mutation in rpsJ affected tigecycline susceptibility by altering the ribosome structure near the tigecycline-binding site or interfering with the coordination of Mg²⁺ ions, which resulted in reduced tigecycline binding to the 16S rRNA therefore reduced the tigecycline susceptibility. Mutations in rpsJ at V57 locus were identified in all resistant isolates through tigecycline resistance screening of E. coli, K. pneumoniae, and A. baumannii, as well as in another report about tigecycline resistant K. pneumoniae from clinical source and laboratory evolution (Beabout et al., 2015; Fang et al., 2016). Other rpsJ mutations, predominantly V57L amino acid substitutions, have been documented in S. maltophilia, K. pneumoniae, E. coli, and A. baumannii with the mutations reducing tigecycline susceptibility by affecting the structure of ribosomal protein S10 (Villa et al., 2014; Hammerstrom et al., 2015; Li et al., 2016a; He et al., 2018; Blanco et al., 2019; Xu et al., 2020; Zhang et al., 2021a). The overexpression of corresponding mutations in E. coli revealed that the majority of amino acid substitutions (V57L, V57D, and V57I) resulted in a modest elevation in tigecycline MICs, while the most pronounced increase was observed in V57L overexpression (Izghirean et al., 2021). However, none of these mutations were as significant as other resistance determinants, such as efflux pumps, on tigecycline susceptibility, suggesting that rpsJ mutation in conjunction with other resistance mutations or determinants is necessary to mediate high-level tigecycline resistance.

A report about a tigecycline resistant A. baumannii has found an amino acid substitution mutation in rrf, the gene encoding the ribosomal recycling factor RRF, with a slight reduction in tigecycline MIC after the complementation of wild-type rrf into the isolate possessed mutated rrf (Hua et al., 2021). Subsequent transcriptome analysis demonstrated that the expression levels of various genes associated with ribosome regulation, energy production, biosynthesis, and transportation increased. The western blotting and polysome profiling revealed that rrf mutants displayed a reduction in RRF expression and an accumulation of 70S ribosomes, suggesting that the mutation in rrf affected the presumed function of RRF in dissociating and recycling tigecycline-bound ribosomes, and at the same time decreased tigecycline’s binding affinity to the ribosomal A-site, leading to a decrease in tigecycline susceptibility. Hammerstrom et al. have discovered other rrf amino acid substitutions, deletion mutations, and upstream mutations in tigecycline resistant A. baumannii obtained through evolution under antibiotic stress (Hammerstrom et al., 2015). rrf mutation has also been identified in a tigecycline resistant S. maltophilia obtained under tigecycline pressure, suggesting that it might play a role in adaptation to tigecycline (Blanco et al., 2019).

In addition to the two ribosome-associated protein mutations previously discussed, mutations in the 30S ribosomal protein S21 encoding gene rpsU and in the ribosomal protein S1 encoding gene rpsA have been reported as potential contributors to tigecycline resistance in S. maltophilia (Hammerstrom et al., 2015).

4.2 Ribosomal protection proteins-related mutations

It has been reported that tigecycline can maintain the binding to 16S rRNA in the presence of the ribosomal protection protein Tet(M) due to the C9-glycyl substituent hinders access of Tet(M) binding to the ribosome, which fails the ribosomal protection (Arenz et al., 2015). This ribosomal protection protein is frequently identified in tigecycline resistant Gram-positive bacteria, whereas among Gram-negative bacteria, it has only been reported to be associated with low tigecycline susceptibility in N. gonorrhoeae (Zhou et al., 2022). The tet(M) gene was carried by the plasmid of N. gonorrhoeae and the correlation analysis revealed that the carriage was significantly correlated with low tigecycline susceptibility (Zhou et al., 2022). Linkevicius et al. have found that tet(M) mutations may result in reduced tigecycline susceptibility (Linkevicius et al., 2015). They overexpressed tet(M) in E. coli and constructed mutant libraries for resistance screening that discovered 13 mutations that could cause increased MICs, in which L505 deletion mutation and the Q620R/S310P mutation combined with S508A significantly elevated tigecycline MICs. Furthermore, the Q620R/S310P combined with S508A caused the most significant MIC elevation. These mutations may contribute to tigecycline susceptibility reduction by affecting the structure and function of Tet(M).

A study about tigecycline resistance A. baumannii screening under antibiotic stress has found a frame-shift in S-adenosylmethionine (SAM)-dependent methyltransferase encoding gene trm due to the deletion mutation, which caused the truncation of the protein and reduced the susceptibility (Chen et al., 2014). The complementation of wild-type trm resulted in the restoration of susceptibility to minocycline, doxycycline, and tigecycline, indicating that the trm mutation might cause the isolate to become resistant to tetracyclines. Methyltransferases serve to safeguard the host genome from foreign DNA and play a vital role in epigenetic regulation and antibiotic resistance. They postulated that trm mutations may facilitate the emergence of tigecycline resistance by interfering with the ribosomal protein methylation. Many other tigecycline resistance-associated amino acid substitutions and deletion mutations in the trm gene have been documented in A. baumannii (Trebosc et al., 2016; Ghalavand et al., 2022).

The rpoB gene, which encodes the β subunit of DNA-dependent RNA polymerase, is evolutionarily conserved. Hua et al. have found a G136D amino acid substitution in rpoB from a tigecycline resistant A. baumannii (Hua et al., 2021). The Raman spectroscopy demonstrated that the overexpression of the mutation rpoB markedly enhanced the isolate’s tolerance to tigecycline, although it only induced a minimal reduction in tigecycline susceptibility. Further transcriptome analysis revealed that multiple transcriptional regulatory genes potentially implicated in stress response and drug resistance exhibited either increased or decreased expression, with a decreased expression of trm and a gene encoding an AcrR/TetR regulatory protein, indicating that the mutant rpoB might be involved in the regulation of trm expression and the transcriptional regulatory genes, thereby conferring resistance to tigecycline.

5 Resistance mechanisms associated with membrane

5.1 Membrane permeability-related mutations

During the tigecycline resistance screening under antibiotic stress, a resistant A. baumannii isolate was generated, wherein a frame-shift mutation was identified in glycerol-3-phosphate acyltransferase encoding gene plsC, resulting in truncation of the protein (Li et al., 2015). The complementation of the wild-type plsC gene recovered the tigecycline MIC reduction, suggesting that plsC was related to decreased tigecycline susceptibility. The alterations in membrane potential were quantified and it implied that the mutant exhibited the highest membrane potential, while it decreased after the wild-type gene complementation, indicating that the mutation might influence the membrane permeability. They speculated that the plsC mutation mediated the tigecycline resistance primarily by affecting the phospholipid synthesis, altering the membrane, and, consequently, increasing the tigecycline permeability.

A mutation in the C13 family peptidase encoding gene abrp has been identified in tigecycline resistant A. baumannii, and the truncation of the protein might be associated with tigecycline resistance (Li et al., 2016b). They demonstrated that the abrp knockout resulted in reduced susceptibility to tigecycline and increased cell membrane permeability in the isolate, whereas complementation with wild-type abrp restored both susceptibility and cell membrane permeability. These findings implied that abrp deletion might affect the membrane permeability and consequently impact the tigecycline susceptibility.

He et al. conducted tigecycline resistance screening in the acrAB knockout and wild-type E. coli isolates and obtained resistant mutants (He et al., 2016). Sequencing analysis revealed that a 2-amino acid deletion in phospholipid translocation-related gene mlaA of the ATP-binding cassette transporter (ABC) transport system was presented in both the knockout and wild-type isolates. This mutation truncated and inactivated the MlaA protein. The tigecycline MICs of mlaA-absent strains remained unchanged, while the complementation strains demonstrated an 8-fold increase in tigecycline MIC. It led to the hypothesis that the mutation in mlaA might enhance phospholipid transfer from the outer to the inner membrane, thereby strengthening the outer membrane barrier and contributing to the resistance. Furthermore, the article identified mutations in marR and rpsJ after the mlaA mutation, suggesting that multiple resistance mechanisms can accumulate during the development of tigecycline resistance.

5.2 Membrane structure-related mutations

In another study of tigecycline resistance induced through antibiotic pressure in A. baumannii, mutations in UDP-N-acetylglucosamine dehydrogenase encoding gene gna and ABC-transporter encoding gene msbA have been identified in the obtained resistant strains and postulated to be associated with tigecycline resistance (Hammerstrom et al., 2015). gna is situated within the K motif, which encodes extracellular polysaccharide biosynthetic enzymes. This enzyme plays a role in the assembly of capsule or lipooligosaccharide (LOS). It is hypothesized that a frame-shift mutation in gna may inactivate the protein and cause structural changes in the capsular polysaccharide or LOS, affecting the rate of diffusion of tigecycline into the cell. MsbA functions as a transporter protein that facilitates the transfer of lipid A from the medial leaflet to the periplasmic side of the inner membrane. As the majority of the observed mutations are concentrated in their substrate-recognition and transmembrane regions, they postulate that mutations may enhance the specificity of the pump, thereby inducing the tigecycline efflux.

An ISAba16 insertion mutation in gnaA was also identified in high-level resistant A. baumannii (Xu et al., 2019). Even though they did not validate the function of the gene, the absence of any other tigecycline resistance-associated genes or mutations in the isolate may also corroborate the hypothesis that the gnaA mutation was correlated with resistance. In a separate study, mutations in tviB, the resistance-related gene encoding the UDP-N-acetylglucosamine dehydrogenase, were identified in A. baumannii (Lucaßen et al., 2021a). This study revealed a high degree of TviB amino acid sequence diversity in both resistant and susceptible isolates, in which a seven amino acid insertion variant might be relevant to tigecycline resistance. The presence of sequence diversity suggests that we need to be cautious in interpreting mutations in tviB and that further characterization is required.

The screening of tigecycline resistance in S. maltophilia also discovered mutations in genes encoding enzymes related to lipopolysaccharide (LPS) biosynthesis and phosphatidic acid biosynthesis, which may relate to tigecycline resistance (Blanco et al., 2019). The mutated genes included the phosphoethanolamine transferase encoding gene, lipid A biosynthesis lauroyl acyltransferase encoding gene htrB, the UDP-glucose dehydrogenase encoding gene ugd, and the diacylglycerol kinase encoding gene dgkA. They hypothesized that the mutations led to impacts on phospholipid and LPS synthesis, modifications of the bacterial outer membrane, preventing the uptake of tigecycline, and therefore increased the resistance to tigecycline.

Inactivation of the TolC-like outer membrane protein AbuO has also been reported in correlation to tigecycline resistance in A. baumannii (Srinivasan et al., 2015). Srinivasan et al. demonstrated a notable reduction in tigecycline MIC in abuO knockout strains, and the RT-qPCR analysis indicated that the expression of efflux pump genes like acrD, and regulatory genes like baeR was elevated. MerR-type transcriptional regulator SoxR binding to abuO promoter revealed that abuO in A. baumannii was regulated by SoxR.

6 Resistance mechanisms associated with DNA repair

In addition to the aforementioned resistance mechanisms, the RecA and RecBCD pathways, which are involved in the regulation of DNA damage induction in A. baumannii, have also been reported to be associated with tigecycline resistance (Ajiboye et al., 2018). The knockout of recA, a homologous recombinase encoding gene involved in DNA damage repair, resulted in increased tigecycline susceptibility. Similarly, the knockout of recB, recC, and recD, genes playing a crucial role in repairing antimicrobial-induced bacterial oxidative DNA damage, led to a relative increase in susceptibility. The involvement of the RecA-RecBCD pathway in tigecycline resistance might be related to the reduced ability of deletion mutant strains to repair DNA.

7 Concluding remarks

Tigecycline, revered as the ‘last line of defense’ against multidrug-resistant bacterial infections, serves as a cornerstone antibiotic in clinical practice. Unraveling the mechanisms underpinning tigecycline resistance is paramount for the antimicrobial resistance prevention. Current insights into resistance mechanisms in Gram-negative bacilli predominantly revolve around efflux pumps and antibiotic modification mechanisms that either expel the drug from the isolates or render it inactive. While less reported, resistance mechanisms impacting drug binding and membrane permeability often exert simultaneous effects on bacterial biosynthesis, as illustrated in Figure 1.

Figure 1

Figure 1. Mechanisms and the regulators of tigecycline resistance in Gram-negative bacilli. OM, outer membrane; IM, inner membrane; red arrow, positive regulation; blue arrow, negative regulation; green arrow, synergistic effect.

Notably, numerous tigecycline resistance genes or determinants, such as TMexCD-TOprJ pumps and tet(X) variants, cluster near mobile genetic elements, signaling an escalating risk of tigecycline resistance dissemination. Attention must be directed towards dissecting the interplay between resistance genes and mobile genetic elements to curb the cross-transmission of tigecycline resistance genes across clinical and environmental spheres. Moreover, certain resistance genes or determinants have been implicated in altering various phenotypes other than tigecycline resistance. The disruption of gnaA, gene related to the capsular polysaccharide synthesis in A. baumannii, can affect the tigecycline resistance as well as the pathogen morphology and virulence through changing the membrane composition (Xu et al., 2019). AcrAB efflux pump can efflux not only tigecycline but also antibacterial molecules such as bile, mammalian steroid hormones, and antimicrobial peptides, which allows them to survive better in the host (Lister et al., 2012). After tigecycline treatment in a patient, mucoid strains resistant to tigecycline were isolated, accompanied by decreased serum tolerance, enhanced biofilm formation ability, and reduced virulence in Galleria mellonella (Zhang et al., 2022). Tigecycline resistant genes or mutations may have collateral effects beyond resistance, such as altered virulence or morphology of the bacteria.

This study offers a comprehensive overview of potential resistance mechanisms to tigecycline in Gram-negative bacilli, elucidating the intricacies and diversities of resistance mechanisms across different species. Furthermore, it also lays the groundwork for preempting tigecycline resistance and identifying fresh avenues for tigecycline-resistant therapies. Delving into new tigecycline resistance mechanisms and conducting detailed explorations of known pathways are imperative to proactively address potential public health crises stemming from antibiotic resistance.

Author contributions

ZW: Writing – review & editing, Conceptualization, Investigation, Writing – original draft. HL: Writing – review & editing, Funding acquisition, Supervision.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Peking University People’s Hospital Research and Development Funds RZ2023-05.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Abd El-Aziz, N. K., Tartor, Y. H., Gharieb, R. M. A., Erfan, A. M., Khalifa, E., Said, M. A., et al. (2021). Extensive drug-resistant salmonella enterica isolated from poultry and humans: prevalence and molecular determinants behind the co-resistance to ciprofloxacin and tigecycline. Front. Microbiol. 12, 738784. doi: 10.3389/fmicb.2021.738784

Crossref Full Text | Google Scholar

Ajiboye, T. O., Skiebe, E., Wilharm, G. (2018). Contributions of RecA and RecBCD DNA repair pathways to the oxidative stress response and sensitivity of Acinetobacter baumannii to antibiotics. Int. J. Antimicrob. Agents. 52, 629–636. doi: 10.1016/j.ijantimicag.2018.07.022

Crossref Full Text | Google Scholar

Akiyama, T., Presedo, J., Khan, A. A. (2013). The tetA gene decreases tigecycline sensitivity of Salmonella enterica isolates. Int. J. Antimicrob. Agents. 42, 133–140. doi: 10.1016/j.ijantimicag.2013.04.017

Crossref Full Text | Google Scholar

Anyanwu, M. U., Nwobi, O. C., Okpala, C. O. R., Ezeonu, I. M. (2022). Mobile tigecycline resistance: an emerging health catastrophe requiring urgent one health global intervention. Front. Microbiol. 13, 808744. doi: 10.3389/fmicb.2022.808744

Crossref Full Text | Google Scholar

Arenz, S., Nguyen, F., Beckmann, R., Wilson, D. N. (2015). Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution. Proc. Natl. Acad. Sci. U.S.A. 112, 5401–5406. doi: 10.1073/pnas.1501775112

Crossref Full Text | Google Scholar

Beabout, K., Hammerstrom, T. G., Perez, A. M., Magalhães, B. F., Prater, A. G., Clements, T. P., et al. (2015). The ribosomal S10 protein is a general target for decreased tigecycline susceptibility. Antimicrob. Agents Chemother. 59, 5561–5566. doi: 10.1128/AAC.00547-15

Crossref Full Text | Google Scholar

Blanco, P., Corona, F., Martinez, J. L. (2019). Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 74, 3221–3230. doi: 10.1093/jac/dkz326

Crossref Full Text | Google Scholar

Bratu, S., Landman, D., George, A., Salvani, J., Quale, J. (2009). Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J. Antimicrob. Chemother. 64, 278–283. doi: 10.1093/jac/dkp186

Crossref Full Text | Google Scholar

Chen, C., Cui, C. Y., Wu, X. T., Fang, L. X., He, Q., He, B., et al. (2021). Spread of tet(X5) and tet(X6) genes in multidrug-resistant Acinetobacter baumannii strains of animal origin. Vet. Microbiol. 253, 108954. doi: 10.1016/j.vetmic.2020.108954

Crossref Full Text | Google Scholar

Chen, C., Cui, C. Y., Yu, J. J., He, Q., Wu, X. T., He, Y. Z., et al. (2020). Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species. Genome Med. 12, 111. doi: 10.1186/s13073-020-00807-5

Crossref Full Text | Google Scholar

Chen, C., Cui, C. Y., Zhang, Y., He, Q., Wu, X. T., Li, G., et al. (2019). Emergence of mobile tigecycline resistance mechanism in Escherichia coli strains from migratory birds in China. Emerg. Microbes Infect. 8, 1219–1222. doi: 10.1080/22221751.2019.1653795

Crossref Full Text | Google Scholar

Chen, C., Huang, P. Y., Cui, C. Y., He, Q., Sun, J., Liu, Y. H., et al. (2022). Classification and molecular characteristics of tet(X)-carrying plasmids in Acinetobacter species. Front. Microbiol. 13, 974432. doi: 10.3389/fmicb.2022.974432

Crossref Full Text | Google Scholar

Chen, Q., Li, X., Zhou, H., Jiang, Y., Chen, Y., Hua, X., et al. (2014). Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase. J. Antimicrob. Chemother. 69, 72–76. doi: 10.1093/jac/dkt319

Crossref Full Text | Google Scholar

Chen, T., Zhao, M., Tang, X., Wang, W., Zhang, M., Tang, J., et al. (2023). Serious risk of tigecycline resistance in escherichia coli isolated from swine manure. Microb. Ecol. 86 (2), 947–958. doi: 10.1007/s00248-022-02133-2

Crossref Full Text | Google Scholar

Chen, Y., Hu, D., Zhang, Q., Liao, X. P., Liu, Y. H., Sun, J. (2017). Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance in Salmonella enterica serovar Typhimurium. Front. Cell Infect. Microbiol. 7, 37. doi: 10.3389/fcimb.2017.00037

Crossref Full Text | Google Scholar

Cheng, Y., Chen, Y., Liu, Y., Guo, Y., Zhou, Y., Xiao, T., et al. (2020). Identification of novel tetracycline resistance gene tet(X14) and its co-occurrence with tet(X2) in a tigecycline-resistant and colistin-resistant Empedobacter stercoris. Emerg. Microbes Infect. 9, 1843–1852. doi: 10.1080/22221751.2020.1803769

Crossref Full Text | Google Scholar

Cheng, Y., Chen, Y., Liu, Y., Song, J., Chen, Y., Shan, T., et al. (2021a). Detection of a new tet(X6)-encoding plasmid in Acinetobacter towneri. J. Glob Antimicrob. Resist. 25, 132–136. doi: 10.1016/j.jgar.2021.03.004

Crossref Full Text | Google Scholar

Cheng, Y., Li, Y., Yu, R., Ma, M., Yang, M., Si, H. (2022). Identification of novel tet(X3) variants resistant to tigecycline in acinetobacter species. Microbiol. Spectr. 10, e0133322. doi: 10.1128/spectrum.01333-22

Crossref Full Text | Google Scholar

Cheng, Y. Y., Liu, Y., Chen, Y., Huang, F. M., Chen, R. C., Xiao, Y. H., et al. (2021b). Sporadic Dissemination of tet(X3) and tet(X6) Mediated by Highly Diverse Plasmidomes among Livestock-Associated Acinetobacter. Microbiol. Spectr. 9, e0114121. doi: 10.1128/Spectrum.01141-21

Crossref Full Text | Google Scholar

Chiu, S. K., Huang, L. Y., Chen, H., Tsai, Y. K., Liou, C. H., Lin, J. C., et al. (2017). Roles of ramR and tet(A) Mutations in Conferring Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates. Antimicrob. Agents Chemother. 61, e00391–e00317. doi: 10.1128/AAC.00391-17

Crossref Full Text | Google Scholar

Coyne, S., Courvalin, P., Périchon, B. (2011). Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 55, 947–953. doi: 10.1128/AAC.01388-10

Crossref Full Text | Google Scholar

Coyne, S., Rosenfeld, N., Lambert, T., Courvalin, P., Périchon, B. (2010). Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 4389–4393. doi: 10.1128/AAC.00155-10

Crossref Full Text | Google Scholar

Damas, M. S. F., Ferreira, R. L., Campanini, E. B., Soares, G. G., Campos, L. C., Laprega, P. M., et al. (2022). Whole genome sequencing of the multidrug-resistant Chryseobacterium indologenes isolated from a patient in Brazil. Front. Med. (Lausanne). 9, 931379. doi: 10.3389/fmed.2022.931379

Crossref Full Text | Google Scholar

Dao, T. D., Kasuga, I., Hirabayashi, A., Nguyen, D. T., Tran, H. T., Vu, H., et al. (2022). Emergence of mobile tigecycline resistance gene tet(X4)-harbouring Shewanella xiamenensis in a water environment. J. Glob Antimicrob. Resist. 28, 140–142. doi: 10.1016/j.jgar.2021.12.022

Crossref Full Text | Google Scholar

Deolankar, M. S., Carr, R. A., Fliorent, R., Roh, S., Fraimow, H., Carabetta, V. J. (2022). Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates. Antibiotics (Basel). 11, 1298. doi: 10.3390/antibiotics11101298

Crossref Full Text | Google Scholar

De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N.A., Schembri, M. A., Beatson, S. A., et al. (2020). Antimicrobial resistance in ESKAPE pathogens. Clin. Microbiol. Rev. 33, e00181–e00119. doi: 10.1128/CMR.00181-19

Crossref Full Text | Google Scholar

Ding, Z., Li, Z., Zhao, Y., Hao, J., Li, T., Liu, Y., et al. (2022). Phenotypic and Genotypic Characteristics of a Tigecycline-Resistant Acinetobacter pittii Isolate Carrying bla_NDM-1 and the Novel bla_OXA Allelic Variant bla_OXA-1045. Front. Microbiol. 13, 868152. doi: 10.3389/fmicb.2022.868152

Crossref Full Text | Google Scholar

Ding, Y., Saw, W. Y., Tan, L. W. L., Moong, D. K.N., Nagarajan, N., Teo, Y. Y., et al. (2020). Emergence of tigecycline- and eravacycline-resistant Tet(X4)-producing Enterobacteriaceae in the gut microbiota of healthy Singaporeans. J. Antimicrob. Chemother. 75, 3480–3484. doi: 10.1093/jac/dkaa372

Crossref Full Text | Google Scholar

Dong, N., Zeng, Y., Cai, C., Sun, C., Lu, J., Liu, C., et al. (2022a). Prevalence, transmission, and molecular epidemiology of tet(X)-positive bacteria among humans, animals, and environmental niches in China: An epidemiological, and genomic-based study. Sci. Total Environ. 818, 151767. doi: 10.1016/j.scitotenv.2021.151767

Crossref Full Text | Google Scholar

Dong, N., Zeng, Y., Wang, Y., Liu, C., Lu, J., Cai, C., et al. (2022b). Distribution and spread of the mobilised RND efflux pump gene cluster tmexCD-toprJ in clinical Gram-negative bacteria: a molecular epidemiological study. Lancet Microbe 3, e846–e856. doi: 10.1016/S2666-5247(22)00221-X

Crossref Full Text | Google Scholar

Fang, L., Chen, Q., Shi, K., Li, X., Shi, Q., He, F., et al. (2016). Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ. PloS One 11, e0165019. doi: 10.1371/journal.pone.0165019

Crossref Full Text | Google Scholar

Foong, W. E., Wilhelm, J., Tam, H. K., Pos, K. M. (2020). Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters. J. Antimicrob. Chemother. 75, 1135–1139. doi: 10.1093/jac/dkaa015

Crossref Full Text | Google Scholar

Gao, X., Wang, C., Lv, L., He, X., Cai, Z., He, W., et al. (2022). Emergence of a Novel Plasmid-Mediated Tigecycline Resistance Gene Cluster, tmexCD4-toprJ4, in Klebsiella quasipneumoniae and Enterobacter roggenkampii. Microbiol. Spectr. 10, e0109422. doi: 10.1128/spectrum.01094-22

Crossref Full Text | Google Scholar

Ghalavand, Z., Eslami, G., Hashemi, A., Sadredinamin, M., Yousefi, N., Dehbanipour, R. (2022). Characterization of sequence types and mechanisms of resistance to tigecycline among acinetobacter baumannii isolated from children. Curr. Microbiol. 79, 285. doi: 10.1007/s00284-022-02976-5

Crossref Full Text | Google Scholar

Gravey, F., Cattoir, V., Ethuin, F., Fabre, L., Beyrouthy, R., Bonnet, R., et al. (2020). ramR deletion in an enterobacter hormaechei isolate as a consequence of therapeutic failure of key antibiotics in a long-term hospitalized patient. Antimicrob. Agents Chemother. 64, e00962–e00920. doi: 10.1128/AAC.00962-20

Crossref Full Text | Google Scholar

Grossman, T. H. (2016). Tetracycline antibiotics and resistance. Cold Spring Harb. Perspect. Med. 6, a025387. doi: 10.1101/cshperspect.a025387

Crossref Full Text | Google Scholar

Guan, C., Tang, B., Yang, H., Ma, J., Huang, Y., Liu, C. (2022). Emergence of plasmid-mediated tigecycline resistance gene, tet(X4), in Escherichia fergusonii from pigs. J. Glob Antimicrob. Resist. 30, 249–251. doi: 10.1016/j.jgar.2022.06.029

Crossref Full Text | Google Scholar

Hammerstrom, T. G., Beabout, K., Clements, T. P., Saxer, G., Shamoo, Y. (2015). Acinetobacter baumannii repeatedly evolves a hypermutator phenotype in response to tigecycline that effectively surveys evolutionary trajectories to resistance. PloS One 10, e0140489. doi: 10.1371/journal.pone.0140489

Crossref Full Text | Google Scholar

Hassan, R. M., Ghaith, D. M., Ismail, D. K., Zafer, M. M. (2018). Reduced susceptibility of Enterococcus spp. isolates from Cairo University Hospital to tigecycline: Highlight on the influence of proton pump inhibitors. J. Glob Antimicrob. Resist. 12, 68–72. doi: 10.1016/j.jgar.2017.12.005

Crossref Full Text | Google Scholar

He, F., Shi, Q., Fu, Y., Xu, J., Yu, Y., Du, X. (2018). Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment. Infect. Genet. Evol. 66, 188–191. doi: 10.1016/j.meegid.2018.09.025

Crossref Full Text | Google Scholar

He, T., Wang, R., Liu, D., Walsh, T. R., Zhang, R., Lv, Y., et al. (2019). Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nat. Microbiol. 4, 1450–1456. doi: 10.1038/s41564-019-0445-2

Crossref Full Text | Google Scholar

He, F., Xu, J., Wang, J., Chen, Q., Hua, X., Fu, Y., et al. (2016). Decreased Susceptibility to Tigecycline Mediated by a Mutation in mlaA in Escherichia coli Strains. Antimicrob. Agents Chemother. 60, 7530–7531. doi: 10.1128/AAC.01603-16

Crossref Full Text | Google Scholar

Hentschke, M., Christner, M., Sobottka, I., Aepfelbacher, M., Rohde, H. (2010a). Combined ramR mutation and presence of a Tn1721-associated tet(A) variant in a clinical isolate of Salmonella enterica serovar Hadar resistant to tigecycline. Antimicrob. Agents Chemother. 54, 1319–1322. doi: 10.1128/AAC.00993-09

Crossref Full Text | Google Scholar

Hentschke, M., Wolters, M., Sobottka, I., Rohde, H., Aepfelbacher, M. (2010b). ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob. Agents Chemother. 54, 2720–2723. doi: 10.1128/AAC.00085-10

Crossref Full Text | Google Scholar

Hirabayashi, A., Dao, T. D., Takemura, T., Hasebe, F., Trang, L. T., Thanh, N. H., et al. (2021). A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla_NDM-4, tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline. mSphere. 6, e0059221. doi: 10.1128/mSphere.00592-21

Crossref Full Text | Google Scholar

Hirata, T., Saito, A., Nishino, K., Tamura, N., Yamaguchi, A. (2004). Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimicrob. Agents Chemother. 48, 2179–2184. doi: 10.1128/AAC.48.6.2179-2184.2004

Crossref Full Text | Google Scholar

Horiyama, T., Nikaido, E., Yamaguchi, A., Nishino, K. (2011). Roles of Salmonella multidrug efflux pumps in tigecycline resistance. J. Antimicrob. Chemother. 66, 105–110. doi: 10.1093/jac/dkq421

Crossref Full Text | Google Scholar

Hornsey, M., Ellington, M. J., Doumith, M., Hudson, S., Livermore, D. M., Woodford, N. (2010). Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome. J. Antimicrob. Chemother. 65, 479–482. doi: 10.1093/jac/dkp475

Crossref Full Text | Google Scholar

Hsieh, Y. C., Wu, J. W., Chen, Y. Y., Quyen, T. L.T., Liao, W. C., Li, S. W., et al. (2021). An Outbreak of tet(X6)-Carrying Tigecycline-Resistant Acinetobacter baumannii Isolates with a New Capsular Type at a Hospital in Taiwan. Antibiotics (Basel). 10, 1239. doi: 10.3390/antibiotics10101239

Crossref Full Text | Google Scholar

Hua, X., He, J., Wang, J., Zhang, L., Zhang, L., Xu, Q., et al. (2021). Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf. Emerg. Microbes Infect. 10, 1404–1417. doi: 10.1080/22221751.2021.1948804

Crossref Full Text | Google Scholar

Izghirean, N., Waidacher, C., Kittinger, C., Chyba, M., Koraimann, G., Pertschy, B., et al. (2021). Effects of ribosomal protein S10 flexible loop mutations on tetracycline and tigecycline susceptibility of escherichia coli. Front. Microbiol. 12, 663835. doi: 10.3389/fmicb.2021.663835

Crossref Full Text | Google Scholar

Jo, J., Ko, K. S. (2021). Tigecycline heteroresistance and resistance mechanism in clinical isolates of acinetobacter baumannii. Microbiol. Spectr. 9, e0101021. doi: 10.1128/Spectrum.01010-21

Crossref Full Text | Google Scholar

Kechagias, K. S., Chorepsima, S., Triarides, N. A., Falagas, M. E. (2020). Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1053–1058. doi: 10.1007/s10096-019-03756-z

Crossref Full Text | Google Scholar

Keeney, D., Ruzin, A., Bradford, P. A. (2007). RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb. Drug Resist. 13, 1–6. doi: 10.1089/mdr.2006.9990

Crossref Full Text | Google Scholar

Keeney, D., Ruzin, A., McAleese, F., Murphy, E., Bradford, P. A. (2008). MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J. Antimicrob. Chemother. 61, 46–53. doi: 10.1093/jac/dkm397

Crossref Full Text | Google Scholar

Li, R., Li, Y., Peng, K., Yin, Y., Liu, Y., He, T., et al. (2021a). Comprehensive Genomic Investigation of Tigecycline Resistance Gene tet(X4)-Bearing Strains Expanding among Different Settings. Microbiol. Spectr. 9, e0163321. doi: 10.1128/spectrum.01633-21

Crossref Full Text | Google Scholar

Li, X., Liu, L., Ji, J., Chen, Q., Hua, X., Jiang, Y., et al. (2015). Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase. Eur. J. Clin. Microbiol. Infect. Dis. 34, 625–631. doi: 10.1007/s10096-014-2272-y

Crossref Full Text | Google Scholar

Li, R., Lu, X., Peng, K., Liu, Z., Li, Y., Liu, Y., et al. (2020). Deciphering the Structural Diversity and Classification of the Mobile Tigecycline Resistance Gene tet(X)-Bearing Plasmidome among Bacteria. mSystems. 5, e00134–e00120. doi: 10.1128/mSystems.00134-20

Crossref Full Text | Google Scholar

Li, R., Mohsin, M., Lu, X., Abdullah, S., Munir, A., Wang, Z. (2021b). Emergence of Plasmid-Mediated Resistance Genes tet(X) and mcr-1 in Escherichia coli Clinical Isolates from Pakistan. mSphere. 6, e0069521. doi: 10.1128/mSphere.00695-21

Crossref Full Text | Google Scholar

Li, X., Mu, X., Yang, Y., Hua, X., Yang, Q., Wang, N., et al. (2016a). Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring bla_NDM-5 in vivo. Int. J. Antimicrob. Agents. 47, 324–327. doi: 10.1016/j.ijantimicag.2016.01.005

Crossref Full Text | Google Scholar

Li, R., Peng, K., Xiao, X., Wang, Y., Wang, Z. (2021c). Characterization of novel ISAba1-bounded tet(X15)-bearing composite transposon Tn6866 in Acinetobacter variabilis. J. Antimicrob. Chemother. 76, 2481–2483. doi: 10.1093/jac/dkab182

Crossref Full Text | Google Scholar

Li, Y., Peng, K., Yin, Y., Sun, X., Zhang, W., Li, R., et al. (2021d). Occurrence and molecular characterization of abundant tet(X) variants among diverse bacterial species of chicken origin in Jiangsu, China. Front. Microbiol. 12, 751006. doi: 10.3389/fmicb.2021.751006

Crossref Full Text | Google Scholar

Li, X., Quan, J., Yang, Y., Ji, J., Liu, L., Fu, Y., et al. (2016b). Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 35, 1371–1375. doi: 10.1007/s10096-016-2674-0

Crossref Full Text | Google Scholar

Li, H., Wang, Q., Wang, R., Zhang, Y., Wang, X., Wang, H. (2017). Global regulator SoxR is a negative regulator of efflux pump gene expression and affects antibiotic resistance and fitness in Acinetobacter baumannii. Med. (Baltimore). 96, e7188. doi: 10.1097/MD.0000000000007188

Crossref Full Text | Google Scholar

Lin, M. F., Lin, Y. Y., Yeh, H. W., Lan, C. Y. (2014). Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility. BMC Microbiol. 14, 119. doi: 10.1186/1471-2180-14-119

Crossref Full Text | Google Scholar

Linkevicius, M., Anderssen, J. M., Sandegren, L., Andersson, D. I. (2016). Fitness of Escherichia coli mutants with reduced susceptibility to tigecycline. J. Antimicrob. Chemother. 71, 1307–1313. doi: 10.1093/jac/dkv486

Crossref Full Text | Google Scholar

Linkevicius, M., Sandegren, L., Andersson, D. I. (2015). Potential of tetracycline resistance proteins to evolve tigecycline resistance. Antimicrob. Agents Chemother. 60, 789–796. doi: 10.1128/AAC.02465-15

Crossref Full Text | Google Scholar

Lister, I. M., Raftery, C., Mecsas, J., Levy, S. B. (2012). Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrob. Agents Chemother. 56, 1120–1123. doi: 10.1128/AAC.05338-11

Crossref Full Text | Google Scholar

Liu, H., Jia, X., Zou, H., Sun, S., Li, S., Wang, Y., et al. (2019). Detection and characterization of tigecycline heteroresistance in E. cloacae: clinical and microbiological findings. Emerg. Microbes Infect. 8, 564–574. doi: 10.1080/22221751.2019.1601031

Crossref Full Text | Google Scholar

Liu, D., Zhai, W., Song, H., Fu, Y., Schwarz, S., He, T., et al. (2020). Identification of the novel tigecycline resistance gene tet(X6) and its variants in Myroides, Acinetobacter and Proteus of food animal origin. J. Antimicrob. Chemother. 75, 1428–1431. doi: 10.1093/jac/dkaa037

Crossref Full Text | Google Scholar

Lucaßen, K., Müller, C., Wille, J., Xanthopoulou, K., Hackel, M., Seifert, H., et al. (2021a). Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey. J. Antimicrob. Chemother. 76, 1724–1730. doi: 10.1093/jac/dkab079

Crossref Full Text | Google Scholar

Lucaßen, K., Xanthopoulou, K., Wille, J., Wille, T., Wen, Y., Hua, X., et al. (2021b). Characterization of amino acid substitutions in the two-component regulatory system adeRS identified in multidrug-resistant acinetobacter baumannii. mSphere. 6, e0070921. doi: 10.1128/msphere.00709-21

Crossref Full Text | Google Scholar

Lv, H., Huang, W., Lei, G., Liu, L., Zhang, L., Yang, X. (2020a). Identification of Novel Plasmids Containing the Tigecycline Resistance Gene tet(X4) in Escherichia coli Isolated from Retail Chicken Meat. Foodborne Pathog. Dis. 17, 792–794. doi: 10.1089/fpd.2020.2822

Crossref Full Text | Google Scholar

Lv, L., Wan, M., Wang, C., Gao, X., Yang, Q., Partridge, S. R., et al. (2020b). Emergence of a plasmid-encoded resistance-nodulation-division efflux pump conferring resistance to multiple drugs, including tigecycline, in klebsiella pneumoniae. mBio. 11, e02930–e02919. doi: 10.1128/mBio.02930-19

Crossref Full Text | Google Scholar

Modarresi, F., Azizi, O., Shakibaie, M. R., Motamedifar, M., Valibeigi, B., Mansouri, S. (2015). Effect of iron on expression of efflux pump (adeABC) and quorum sensing (luxI, luxR) genes in clinical isolates of Acinetobacter baumannii. APMIS. 123, 959–968. doi: 10.1111/apm.2015.123.issue-11

Crossref Full Text | Google Scholar

Moghimi, M., Haeili, M., Mohajjel Shoja, H. (2021). Characterization of Tigecycline Resistance Among Tigecycline Non-susceptible Klebsiella pneumoniae Isolates From Humans, Food-Producing Animals, and in vitro Selection Assay. Front. Microbiol. 12, 702006. doi: 10.3389/fmicb.2021.702006

Crossref Full Text | Google Scholar

Mohsin, M., Hassan, B., Martins, W. M. B. S., Li, R., Abdullah, S., Sands, K., et al. (2021). Emergence of plasmid-mediated tigecycline resistance tet(X4) gene in Escherichia coli isolated from poultry, food and the environment in South Asia. Sci. Total Environ. 787, 147613. doi: 10.1016/j.scitotenv.2021.147613

Crossref Full Text | Google Scholar

Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., Wilson, D. (2014). Tetracycline antibiotics and resistance mechanisms. Biol. Chem. 395, 559–575. doi: 10.1515/hsz-2013-0292

Crossref Full Text | Google Scholar

Nicoloff, H., Andersson, D. I. (2013). Lon protease inactivation, or translocation of the lon gene, potentiate bacterial evolution to antibiotic resistance. Mol. Microbiol. 90, 1233–1248. doi: 10.1111/mmi.2013.90.issue-6

Crossref Full Text | Google Scholar

Nielsen, S. M., Penstoft, L. N., Nørskov-Lauritsen, N. (2019). Motility, biofilm formation and antimicrobial efflux of sessile and planktonic cells of achromobacter xylosoxidans. Pathogens. 8, 14. doi: 10.3390/pathogens8010014

Crossref Full Text | Google Scholar

Nielsen, L. E., Snesrud, E. C., Onmus-Leone, F., Kwak, Y. I., Avilés, R., Steele, E. D., et al. (2014). IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 58, 6151–6156. doi: 10.1128/AAC.03053-14

Crossref Full Text | Google Scholar

Pankey, G. A. (2005). Tigecycline. J. Antimicrob. Chemother. 56, 470–480. doi: 10.1093/jac/dki248

Crossref Full Text | Google Scholar

Peng, Z., Hu, Z., Li, Z., Zhang, X., Jia, C., Li, T., et al. (2022a). Antimicrobial resistance and population genomics of multidrug-resistant Escherichia coli in pig farms in mainland China. Nat. Commun. 13, 1116. doi: 10.1038/s41467-022-28750-6

Crossref Full Text | Google Scholar

Peng, K., Wang, Q., Li, Y., Wang, M., Kurekci, C., Li, R., et al. (2022b). Molecular mechanisms and genomic basis of tigecycline-resistant Enterobacterales from swine slaughterhouses. Microbiol. Res. 264, 127151. doi: 10.1016/j.micres.2022.127151

Crossref Full Text | Google Scholar

Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E., Testa, R. T. (1999). In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43, 738–744. doi: 10.1128/AAC.43.4.738

Crossref Full Text | Google Scholar

Pournaras, S., Koumaki, V., Spanakis, N., Gennimata, V., Tsakris, A. (2016). Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. Int. J. Antimicrob. Agents. 48, 11–18. doi: 10.1016/j.ijantimicag.2016.04.017

Crossref Full Text | Google Scholar

Roy, S., Datta, S., Viswanathan, R., Singh, A. K., Basu, S. (2013). Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. J. Antimicrob. Chemother. 68, 1036–1042. doi: 10.1093/jac/dks535

Crossref Full Text | Google Scholar

Rumbo, C., Gato, E., López, M., Ruiz de Alegría, C., Fernández-Cuenca, F., Martínez-Martínez, L., et al. (2013). Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 57, 5247–5257. doi: 10.1128/AAC.00730-13

Crossref Full Text | Google Scholar

Salehi, B., Ghalavand, Z., Yadegar, A., Eslami, G. (2021). Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of Acinetobacter baumannii. Antimicrob. Resist. Infect. Control. 10, 53. doi: 10.1186/s13756-021-00924-9

Crossref Full Text | Google Scholar

Sheng, Z. K., Hu, F., Wang, W., Guo, Q., Chen, Z., Xu, X., et al. (2014). Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob. Agents Chemother. 58, 6982–6985. doi: 10.1128/AAC.03808-14

Crossref Full Text | Google Scholar

Soliman, A. M., Ramadan, H., Zarad, H., Sugawara, Y., Yu, L., Sugai, M., et al. (2021). Coproduction of tet(X7) conferring high-level tigecycline resistance, fosfomycin fosA4, and colistin mcr-1.1 in escherichia coli strains from chickens in Egypt. Antimicrob. Agents Chemother. 65, e02084–e02020. doi: 10.1128/AAC.02084-20

Crossref Full Text | Google Scholar

Srinivasan, V. B., Vaidyanathan, V., Rajamohan, G. (2015). AbuO, a TolC-like outer membrane protein of Acinetobacter baumannii, is involved in antimicrobial and oxidative stress resistance. Antimicrob. Agents Chemother. 59, 1236–1245. doi: 10.1128/AAC.03626-14

Crossref Full Text | Google Scholar

Sun, J., Chen, C., Cui, C. Y., Zhang, Y., Liu, X., Cui, Z. H., et al. (2019). Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. Nat. Microbiol. 4, 1457–1464. doi: 10.1038/s41564-019-0496-4

Crossref Full Text | Google Scholar

Sun, S., Gao, H., Liu, Y., Jin, L., Wang, R., Wang, X., et al. (2020). Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in Klebsiella pneumoniae. Emerg. Microbes Infect. 9, 1102–1113. doi: 10.1080/22221751.2020.1768805

Crossref Full Text | Google Scholar

Sun, J. R., Jeng, W. Y., Perng, C. L., Yang, Y. S., Soo, P. C., Chiang, Y. S., et al. (2016). Single amino acid substitution Gly186Val in AdeS restores tigecycline susceptibility of Acinetobacter baumannii. J. Antimicrob. Chemother. 71, 1488–1492. doi: 10.1093/jac/dkw002

Crossref Full Text | Google Scholar

Sun, S., Wang, Q., Jin, L., Guo, Y., Yin, Y., Wang, R., et al. (2022). Identification of multiple transfer units and novel subtypes of tmexCD-toprJ gene clusters in clinical carbapenem-resistant Enterobacter cloacae and Klebsiella oxytoca. J. Antimicrob. Chemother. 77, 625–632. doi: 10.1093/jac/dkab434

Crossref Full Text | Google Scholar

Sun, X., Zhang, B., Xu, G., Chen, J., Shang, Y., Lin, Z., et al. (2021). In vitro activity of the novel tetracyclines, tigecycline, eravacycline, and omadacycline, against moraxella catarrhalis. Ann. Lab. Med. 41, 293–301. doi: 10.3343/alm.2021.41.3.293

Crossref Full Text | Google Scholar

Tang, B., Yang, H., Jia, X., Feng, Y. (2021). Coexistence and characterization of Tet(X5) and NDM-3 in the MDR-Acinetobacter indicus of duck origin. Microb. Pathog. 150, 104697. doi: 10.1016/j.micpath.2020.104697

Crossref Full Text | Google Scholar

Trebosc, V., Gartenmann, S., Royet, K., Manfredi, P., Tötzl, M., Schellhorn, B., et al. (2016). A novel genome-editing platform for drug-resistant acinetobacter baumannii reveals an adeR-unrelated tigecycline resistance mechanism. Antimicrob. Agents Chemother. 60, 7263–7271. doi: 10.1128/AAC.01275-16

Crossref Full Text | Google Scholar

Umar, Z., Chen, Q., Tang, B., Xu, Y., Wang, J., Zhang, H., et al. (2021). The poultry pathogen Riemerella anatipestifer appears as a reservoir for Tet(X) tigecycline resistance. Environ. Microbiol. 23, 7465–7482. doi: 10.1111/1462-2920.15632

Crossref Full Text | Google Scholar

Usui, M., Fukuda, A., Suzuki, Y., Nakajima, C., Tamura, Y. (2022). Broad-host-range IncW plasmid harbouring tet(X) in Escherichia coli isolated from pigs in Japan. J. Glob Antimicrob. Resist. 28, 97–101. doi: 10.1016/j.jgar.2021.12.012

Crossref Full Text | Google Scholar

Veleba, M., De Majumdar, S., Hornsey, M., Woodford, N., Schneiders, T. (2013). Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Antimicrob. Chemother. 68, 1011–1018. doi: 10.1093/jac/dks530

Crossref Full Text | Google Scholar

Veleba, M., Higgins, P. G., Gonzalez, G., Seifert, H., Schneiders, T. (2012a). Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56, 4450–4458. doi: 10.1128/AAC.00456-12

Crossref Full Text | Google Scholar

Veleba, M., Schneiders, T. (2012b). Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56, 4466–4467. doi: 10.1128/AAC.06224-11

Crossref Full Text | Google Scholar

Villa, L., Feudi, C., Fortini, D., García-Fernández, A., Carattoli, A. (2014). Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob. Agents Chemother. 58, 1707–1712. doi: 10.1128/AAC.01803-13

Crossref Full Text | Google Scholar

Wang, X., Chen, H., Zhang, Y., Wang, Q., Zhao, C., Li, H., et al. (2015). Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR. Int. J. Antimicrob. Agents. 45, 635–640. doi: 10.1016/j.ijantimicag.2014.12.022

Crossref Full Text | Google Scholar

Wang, C. Z., Gao, X., Lv, L. C., Cai, Z. P., Yang, J., Liu, J. H. (2021a). Novel tigecycline resistance gene cluster tnfxB3-tmexCD3-toprJ1b in Proteus spp. and Pseudomonas aeruginosa, co-existing with tet(X6) on an SXT/R391 integrative and conjugative element. J. Antimicrob. Chemother. 76, 3159–3167. doi: 10.1093/jac/dkab325

Crossref Full Text | Google Scholar

Wang, C. Z., Gao, X., Yang, Q. W., Lv, L. C., Wan, M., Yang, J., et al. (2021b). A Novel Transferable Resistance-Nodulation-Division Pump Gene Cluster, tmexCD2-toprJ2, Confers Tigecycline Resistance in Raoultella ornithinolytica. Antimicrob. Agents Chemother. 65, e02229–e02220. doi: 10.1128/AAC.02229-20

Crossref Full Text | Google Scholar

Wang, Z., Li, H., Zhang, J., Wang, X., Zhang, Y., Wang, H. (2021c). Identification of a novel plasmid-mediated tigecycline resistance-related gene, tet(Y), in Acinetobacter baumannii. J. Antimicrob. Chemother. 77, 58–68. doi: 10.1093/jac/dkab375

Crossref Full Text | Google Scholar

Wang, L., Liu, D., Lv, Y., Cui, L., Li, Y., Li, T., et al. (2019). Novel Plasmid-Mediated tet(X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate. Antimicrob. Agents Chemother. 64, e01326–e01319. doi: 10.1128/AAC.01326-19

Crossref Full Text | Google Scholar

Wang, J., Lu, M. J., Wang, Z. Y., Jiang, Y., Wu, H., Pan, Z. M., et al. (2022a). Tigecycline-resistant Escherichia coli ST761 carrying tet(X4) in a pig farm, China. Front. Microbiol. 13, 967313. doi: 10.3389/fmicb.2022.967313

Crossref Full Text | Google Scholar

Wang, J., Lu, M. J., Wu, H., Wang, Z. Y., Mei, C. Y., Tian, Y. Q., et al. (2022b). Plasmid-borne tet(X3) and chromosome-borne tet(X6) in porcine Acinetobacter isolates. J. Glob Antimicrob. Resist. 29, 17–19. doi: 10.1016/j.jgar.2022.01.024

Crossref Full Text | Google Scholar

Wang, Y., Zhu, B., Liu, M., Dong, X., Ma, J., Li, X., et al. (2021d). Characterization of IncHI1B Plasmids Encoding Efflux Pump TmexCD2-ToprJ2 in Carbapenem-Resistant Klebsiella variicola, Klebsiella quasipneumoniae, and Klebsiella michiganensis Strains. Front. Microbiol. 12, 759208. doi: 10.3389/fmicb.2021.759208

Crossref Full Text | Google Scholar

Whittle, G., Hund, B. D., Shoemaker, N. B., Salyers, A. A. (2001). Characterization of the 13-kilobase ermF region of the Bacteroides conjugative transposon CTnDOT. Appl. Environ. Microbiol. 67, 3488–3495. doi: 10.1128/AEM.67.8.3488-3495.2001

Crossref Full Text | Google Scholar

Xu, Q., Chen, T., Yan, B., Zhang, L., Pi, B., Yang, Y., et al. (2019). Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii. Antimicrob. Agents Chemother. 63, e00694–e00619. doi: 10.1128/AAC.00694-19

Crossref Full Text | Google Scholar

Xu, Y., Liu, L., Zhang, H., Feng, Y. (2021a). Co-production of Tet(X) and MCR-1, two resistance enzymes by a single plasmid. Environ. Microbiol. 23, 7445–7464. doi: 10.1111/1462-2920.15425

Crossref Full Text | Google Scholar

Xu, J., Zhao, Z., Ge, Y., He, F. (2020). Rapid emergence of a pandrug-resistant klebsiella pneumoniae ST11 isolate in an inpatient in a teaching hospital in China after treatment with multiple broad-spectrum antibiotics. Infect. Drug Resist. 13, 799–804. doi: 10.2147/IDR.S243334

Crossref Full Text | Google Scholar

Xu, J., Zhu, Z., Chen, Y., Wang, W., He, F. (2021b). The Plasmid-Borne tet(A) Gene Is an Important Factor Causing Tigecycline Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae Under Selective Pressure. Front. Microbiol. 12, 644949. doi: 10.3389/fmicb.2021.644949

Crossref Full Text | Google Scholar

Yaghoubi, S., Zekiy, A. O., Krutova, M., Gholami, M., Kouhsari, E., Sholeh, M., et al. (2022). Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur. J. Clin. Microbiol. Infect. Dis. 41, 1003–1022. doi: 10.1007/s10096-020-04121-1

Crossref Full Text | Google Scholar

Yang, Y. S., Chen, H. Y., Hsu, W. J., Chou, Y. C., Perng, C. L., Shang, H. S., et al. (2019). Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates. Clin. Microbiol. Infect. 25, 512.e1–512.e6. doi: 10.1016/j.cmi.2018.06.012

Crossref Full Text | Google Scholar

Yang, W., Moore, I. F., Koteva, K. P., Bareich, D. C., Hughes, D. W., Wright, G. D. (2004). TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J. Biol. Chem. 279, 52346–52352. doi: 10.1074/jbc.M409573200

Crossref Full Text | Google Scholar

Yao, H., Jiao, D., Zhao, W., Li, A., Li, R., Du, X. D. (2020). Emergence of a Novel tet(L) Variant in Campylobacter spp. of Chicken Origin in China. Antimicrob. Agents Chemother. 65, e01622–e01620. doi: 10.1128/AAC.01622-20

Crossref Full Text | Google Scholar

Yoon, E. J., Chabane, Y. N., Goussard, S., Snesrud, E., Courvalin, P., Dé, E., et al. (2015). Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. mBio. 6, e00309–e00315. doi: 10.1128/mBio.00309-15

Crossref Full Text | Google Scholar

Yoon, E. J., Courvalin, P., Grillot-Courvalin, C. (2013). RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob. Agents Chemother. 57, 2989–2995. doi: 10.1128/AAC.02556-12

Crossref Full Text | Google Scholar

Zeng, Y., Dong, N., Zhang, R., Liu, C., Sun, Q., Lu, J., et al. (2020). Emergence of an Empedobacter falsenii strain harbouring a tet(X)-variant-bearing novel plasmid conferring resistance to tigecycline. J. Antimicrob. Chemother. 75, 531–536. doi: 10.1093/jac/dkz489

Crossref Full Text | Google Scholar

Zhai, W., Tian, Y., Lu, M., Zhang, M., Song, H., Fu, Y., et al. (2022). Presence of Mobile Tigecycline Resistance Gene tet(X4) in Clinical Klebsiella pneumoniae. Microbiol. Spectr. 10, e0108121. doi: 10.1128/spectrum.01081-21

Crossref Full Text | Google Scholar

Zhang, R., Dong, N., Zeng, Y., Shen, Z., Lu, J., Liu, C., et al. (2020). Chromosomal and Plasmid-Borne Tigecycline Resistance Genes tet(X3) and tet(X4) in Dairy Cows on a Chinese Farm. Antimicrob. Agents Chemother. 64, e00674–e00620. doi: 10.1128/AAC.00674-20

Crossref Full Text | Google Scholar

Zhang, Q., Lin, L., Pan, Y., Chen, J. (2021a). Characterization of tigecycline-heteroresistant klebsiella pneumoniae clinical isolates from a chinese tertiary care teaching hospital. Front. Microbiol. 12, 671153. doi: 10.3389/fmicb.2021.671153

Crossref Full Text | Google Scholar

Zhang, R. M., Sun, J., Sun, R. Y., Wang, M. G., Cui, C. Y., Fang, L. X., et al. (2021b). Source tracking and global distribution of the tigecycline-nonsusceptible tet(X). Microbiol. Spectr. 9, e0116421. doi: 10.1128/Spectrum.01164-21

Crossref Full Text | Google Scholar

Zhang, Y., Wang, X., Wang, Q., Chen, H., Li, H., Wang, S., et al. (2021c). Emergence of tigecycline nonsusceptible and IMP-4 carbapenemase-producing K2-ST65 hypervirulent klebsiella pneumoniae in China. Microbiol. Spectr. 9, e0130521. doi: 10.1128/Spectrum.01305-21

Crossref Full Text | Google Scholar

Zhang, J., Xie, J., Li, H., Wang, Z., Yin, Y., Wang, S., et al. (2022). Genomic and phenotypic evolution of tigecycline-resistant acinetobacter baumannii in critically ill patients. Microbiol. Spectr. 10, e0159321. doi: 10.1128/spectrum.01593-21

Crossref Full Text | Google Scholar

Zheng, X. R., Zhu, J. H., Zhang, J., Cai, P., Sun, Y. H., Chang, M. X., et al. (2020). A novel plasmid-borne tet(X6) variant co-existing with bla_NDM-1 and bla_OXA-58 in a chicken Acinetobacter baumannii isolate. J. Antimicrob. Chemother. 75, 3397–3399. doi: 10.1093/jac/dkaa342

Crossref Full Text | Google Scholar

Zhong, X., Xu, H., Chen, D., Zhou, H., Hu, X., Cheng, G. (2014). First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. PloS One 9, e115185. doi: 10.1371/journal.pone.0115185

Crossref Full Text | Google Scholar

Zhou, Q., Xu, W., Zhu, X., Zhang, J., Zhang, Y., Han, Y., et al. (2022). Evaluation of neisseria gonorrhoeae isolates susceptibility to tetracycline antibiotics from 9 provinces in China since 2020. Infect. Drug Resist. 15, 1383–1389. doi: 10.2147/IDR.S352932

Crossref Full Text | Google Scholar

Zhu, D., Wei, X., Zhu, H., Yang, Z., Wang, M., Jia, R., et al. (2022). Emergence of plasmid-mediated tigecycline, β-lactam and florfenicol resistance genes tet(X), bla_OXA-347 and floR in Riemerella anatipestifer isolated in China. Poult Sci. 101, 102057. doi: 10.1016/j.psj.2022.102057

Crossref Full Text | Google Scholar